Page last updated: 2024-10-29

iohexol and Neoplasm Metastasis, Unknown Primary

iohexol has been researched along with Neoplasm Metastasis, Unknown Primary in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Douglas, C1
Crosbie, R1
Young, D1
Montgomery, J1
O'Neill, G1
McArthur, C1

Other Studies

1 other study available for iohexol and Neoplasm Metastasis, Unknown Primary

ArticleYear
Accuracy of contrast-enhanced CT and predictive factors for extracapsular spread in unknown primary head and neck squamous cell cancer.
    Clinical radiology, 2020, Volume: 75, Issue:1

    Topics: Adult; Aged; Carcinoma, Squamous Cell; Contrast Media; Female; Head and Neck Neoplasms; Humans; Iohe

2020
chemdatabank.com